Finance

Lists
4164:TADAWUL
Al Nahdi Medical Company SJSC
SAR 89,45
-0,06%
(-0,050) 1D
13 Okt., 15:16:02 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4164...
Open
SAR 89,55
High
SAR 89,65
Low
SAR 88,75
Mkt. cap
11,63 mjd
Avg. vol.
91,62 k
Volume
78,33 k
Dividend
6,26%
Quarterly dividend
SAR 1,40
Ex-dividend date
16 Aug. 2026
P/E ratio
14,76
52-wk high
SAR 122,70
52-wk low
SAR 88,75
EPS
SAR 6,06
Shares outstanding
80,35 m
No. of employees
6 k
Open
SAR 89,55
High
SAR 89,65
Low
SAR 88,75
Mkt. cap
11,63 mjd
Avg. vol.
91,62 k
Volume
78,33 k
Dividend
6,26%
Quarterly dividend
SAR 1,40
Ex-dividend date
16 Aug. 2026
P/E ratio
14,76
52-wk high
SAR 122,70
52-wk low
SAR 88,75
EPS
SAR 6,06
Shares outstanding
80,35 m
No. of employees
6 k
News stories
From web sources and news partners
About Al Nahdi Medical Company SJSC
CEO-
Employees6,15 k
Founded1986
Headquarters-
SectorDrug
Websitenahdi.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,46 mjd
2,59 mjd
2,79 mjd
2,67 mjd
Cost of goods sold
1,52 mjd
1,75 mjd
1,81 mjd
1,67 mjd
Cost of revenue
1,52 mjd
1,75 mjd
1,81 mjd
1,67 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
756,61 m
630,42 m
734,17 m
766,43 m
Operating expense
753,00 m
633,76 m
727,99 m
761,77 m
Total operating expenses
2,27 mjd
2,38 mjd
2,53 mjd
2,43 mjd
Operating income
187,57 m
207,85 m
259,74 m
245,86 m
Other non operating income
63,00
-52,76 m
210,15 k
344,39 k
EBT including unusual items
166,46 m
188,39 m
239,22 m
222,53 m
EBT excluding unusual items
166,46 m
187,90 m
239,00 m
217,61 m
Income tax expense
5,21 m
12,47 m
3,54 m
7,30 m
Effective tax rate
3,13%
6,62%
1,48%
3,28%
Other operating expenses
-3,61 m
3,34 m
-6,18 m
-4,66 m
Net income
161,25 m
175,92 m
235,68 m
215,23 m
Net profit margin
6,55%
6,79%
8,43%
8,05%
Earnings per share
-
-
-
-
Interest and investment income
16,28 m
22,55 m
14,37 m
7,79 m
Interest expense
-37,39 m
-1,12 m
-35,32 m
-36,38 m
Net interest expenses
-21,11 m
21,44 m
-20,95 m
-28,59 m
Depreciation and amortization charges
-
-
-
-
EBITDA
261,10 m
282,78 m
334,35 m
320,97 m
Gain or loss from assets sale
-74,66 k
-411,45 k
-60,72 k
-155,21 k
AI content may include mistakes. Learn more
Google-programme